{"id":"W4378348677","doi":"10.1111/dom.15099","title":"Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator <scp>BI</scp> 685509 in patients with diabetic kidney disease: A randomized trial","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Department of Medicine, University of Toronto; Canadian Institutes of Health Research; Kidney Foundation of Canada; University of Toronto; Diabetes Canada; Boehringer Ingelheim","keywords":"Placebo; Medicine; Renal function; Albuminuria; Internal medicine; Kidney disease; Tolerability; Creatinine; Pharmacodynamics; Urology; Endocrinology; Gastroenterology; Adverse effect; Pharmacokinetics; Pharmacology; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001307955,0.0009853519,0.001890878,0.0002248267,0.0002833223,0.0008546631,0.0005117347,0.001131316,0.004064403],"category_scores_gemma":[0.00113607,0.0003914579,0.001248703,0.0003205326,0.0007147418,0.00049706,0.0002296485,0.001723099,0.000558898],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006060523,"about_ca_system_score_gemma":0.000748131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009522344,"about_ca_topic_score_gemma":0.001855695,"domain_scores_codex":[0.9994807,0.0002827928,0.00004639521,0.00007946059,0.00004052111,0.00007022358],"domain_scores_gemma":[0.9992936,0.0001571307,0.0002387787,0.00004181975,0.00004076035,0.0002279857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9738001,0.002569269,0.001122521,0.0005712654,0.0009907811,0.00004152261,0.00003284464,0.0002553039,0.003914447,0.00008420723,0.0007956508,0.01582208],"study_design_scores_gemma":[0.9309385,0.06231382,0.00418404,0.00004404996,0.0007515742,0.00004837979,0.00001764996,0.0005655942,0.0004547206,0.0001003518,0.000565753,0.0000156316],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991666,0.004007525,0.0003623629,0.000458396,0.0001977796,0.001335716,0.0006467929,0.00006946407,0.001255976],"genre_scores_gemma":[0.9947695,0.001475882,0.0005231995,0.0006630755,0.0001777154,0.001062397,0.0004862609,0.000008993726,0.0008329765],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004064403,"threshold_uncertainty_score":0.01359683,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004590596198653822,"score_gpt":0.2136778150039021,"score_spread":0.2090872188052483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}